ACR/ARHP 2016 Conference Review - focus on Biologics

In this review:

Biologics have improved RA functional status
Steroid-sparing tocilizumab regimen in GCA
RA immune ‘signature’ individualises clinical management
Reassuring registry data on Remicade® to Remsima™ switch
Switching from Remicade® to Remsima™: no negative impact on drug levels or ADA
ABT-122 vs adalimumab in active PsA
Secukinumab: no increased risk of IBD in psoriasis, PsA, or AS
Does the gut microbiome predict response to MTX?

Please login below to download this issue (PDF)

Subscribe